| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.8 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | -0.0069 | 0.9 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.9 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.9 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.0068 | 0.9 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.0073 | 0.9 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | -0.01 | 0.9 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.0099 | 0.9 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | -0.007 | 0.9 |